Serum total bilirubin concentration is associated with carotid atherosclerosis in patients with prehypertension

References

• Morales SA, Coca A, Olsen MH, Sanchez RA, Sebba-Barroso WK, Kones R, Bertomeu-Martinez V, Sobrino J, Alcocer L, Pineiro DJ, et al. Clinical perspective on antihypertensive drug treatment in adults with grade 1 hypertension and low-to-moderate cardiovascular risk: an international expert consultation. Curr Probl Cardiol. 2017;42:198–225. doi:10.1016/j.cpcardiol.2017.03.001.
   PubMed Web of Science ®Google Scholar
• Williams B, Mancia G, Spiering W, Agabiti Rosei E, Azizi M, Burnier M, Clement DL, Coca A, de Simone G, Dominiczak A, et al. 2018 ESC/ESH Guidelines for the management of arterial hypertension. Eur Heart J. 2018;39:3021–104. doi:10.1093/eurheartj/ehy339.
   PubMed Web of Science ®Google Scholar
• Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL, Jones DW, Materson BJ, Oparil S, Wright JT, et al. The seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure: the JNC 7 report. JAMA. 2003;289:2560–72. doi:10.1001/jama.289.19.2560.
   PubMed Web of Science ®Google Scholar
• Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL, Jones DW, Materson BJ, Oparil S, Wright JT, et al. Seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure. Hypertension. 2003;42:1206–52. doi:10.1161/01.HYP.0000107251.49515.c2.
   PubMed Web of Science ®Google Scholar
• Egan BM, Stevens-Fabry S. Prehypertension–prevalence, health risks, and management strategies. Nat Rev Cardiol. 2015;12:289–300. doi:10.1038/nrcardio.2015.17.
   PubMed Web of Science ®Google Scholar
• Liu B, Chen Z, Dong X, Qin G. Association of prehypertension and hyperhomocysteinemia with subclinical atherosclerosis in asymptomatic Chinese: a cross-sectional study. BMJ Open. 2018;8:e19829–35. doi:10.1136/bmjopen-2017-019829.
   PubMed Web of Science ®Google Scholar
• Polak JF, Pencina MJ, Pencina KM, O’Donnell CJ, Wolf PA, D’Agostino RB. Carotid-wall intima-media thickness and cardiovascular events. N Engl J Med. 2011;365:213–21. doi:10.1056/NEJMoa1012592.
   PubMed Web of Science ®Google Scholar
• Nambi V, Pedroza C, Kao LS. Carotid intima-media thickness and cardiovascular events. Lancet. 2012;379:2028–30. doi:10.1016/S0140-6736(12)60652-7.
   PubMed Web of Science ®Google Scholar
• Stark J. Oxidative stress and atherosclerosis. Orv Hetil. 2015;156:1115–19. doi:10.1556/650.2015.30201.
   PubMed Web of Science ®Google Scholar
• Taleb A, Ahmad KA, Ihsan AU, Qu J, Lin N, Hezam K, Koju N, Hui L, Qilong D. Antioxidant effects and mechanism of silymarin in oxidative stress induced cardiovascular diseases. Biomed Pharmacother. 2018;102:689–98. doi:10.1016/j.biopha.2018.03.140.
   PubMed Web of Science ®Google Scholar
• Li H, Horke S, Forstermann U. Vascular oxidative stress, nitric oxide and atherosclerosis. Atherosclerosis. 2014;237:208–19. doi:10.1016/j.atherosclerosis.2014.09.001.
   PubMed Web of Science ®Google Scholar
• Jin J, Wang W, Gu T, Chen C, Sun J, Chen W, Bi Y, Zhu D. Low serum bilirubin levels contribute to the presence and progression of distal symmetrical polyneuropathy in Chinese patients with type 2 diabetes. Diabetes Metab.2018;18:1–6.
   Google Scholar
• Horsfall LJ, Nazareth I, Petersen I. Cardiovascular events as a function of serum bilirubin levels in a large, statin-treated cohort. Circulation. 2012;126:2556–64. doi:10.1161/CIRCULATIONAHA.112.114066.
   PubMed Web of Science ®Google Scholar
• Li Y, Meng SY, Meng CC, Yu W-G, Wang R-T. Decreased serum bilirubin is associated with arterial stiffness in men. Nutr Metab Cardiovasc Dis. 2013;23:375–81. doi:10.1016/j.numecd.2011.09.004.
   PubMed Web of Science ®Google Scholar
• Vitek L, Novotny L, Sperl M, Holaj R, Spácil J. The inverse association of elevated serum bilirubin levels with subclinical carotid atherosclerosis. Cerebrovasc Dis. 2006;21:408–14. doi:10.1159/000091966.
   PubMed Web of Science ®Google Scholar
• Huang YQ, Cai AP, Chen JY, Huang C, Li J, Feng Y-Q. The relationship of plasma miR-29a and oxidized low density lipoprotein with atherosclerosis. Cell Physiol Biochem. 2016;40:1521–28. doi:10.1159/000453202.
   PubMed Web of Science ®Google Scholar
• Biasucci LM, La Rosa G, Pedicino D, D’Aiello A, Galli M, Liuzzo G. Where does inflammation fit? Curr Cardiol Rep. 2017;19:84–94. doi:10.1007/s11886-017-0896-0.
   PubMed Web of Science ®Google Scholar
•  Demirkol S, Balta S, Celik T, Unlu M, Arslan Z, Cakar M, Kucuk U, Iyisoy A, Barcin C, Demirbas S, Kocak N, Cayci T. Carotid intima media thickness and its association with total bilirubin levels in patients with coronary artery ectasia. Angiology.2013;1:1–6.
   Google Scholar
• Zhang ZY, Bian LQ, Jae SY, Sung J-D, Choi Y-H. Serum total bilirubin is inversely associated with brachial-ankle pulse wave velocity in men with hypertension. Heart Vessels. 2013;28:453–60. doi:10.1007/s00380-012-0261-6.
   PubMed Web of Science ®Google Scholar
• Stocker R, Yamamoto Y, McDonagh AF, Glazer AN, Ames BN. Bilirubin is an antioxidant of possible physiological importance. Science. 1987;235:1043–46.
   PubMed Web of Science ®Google Scholar
• Wang HM, Chen TC, Jiang SQ, Liu Y-J, Tian J-W. Association of conventional risk factors for cardiovascular disease with IMT in middle-aged and elderly Chinese. Int J Cardiovasc Imaging. 2014;30:759–68. doi:10.1007/s10554-014-0399-7.
   PubMed Web of Science ®Google Scholar
• Carpenter M, Sinclair H, Kunadian V. Carotid intima media thickness and its utility as a predictor of cardiovascular disease: a review of evidence. Cardiol Rev. 2016;24:70–75. doi:10.1097/CRD.0000000000000077.
   PubMed Web of Science ®Google Scholar
• Novotny L, Vitek L. Inverse relationship between serum bilirubin and atherosclerosis in men: a meta-analysis of published studies. Exp Biol Med (Maywood). 2003;228:568–71.
   PubMed Web of Science ®Google Scholar
• Dullaart RP, Kappelle PJ, de Vries R. Lower carotid intima media thickness is predicted by higher serum bilirubin in both non-diabetic and Type 2 diabetic subjects. Clin Chim Acta. 2012;414:161–65. doi:10.1016/j.cca.2012.08.029.
   PubMed Web of Science ®Google Scholar
• Huang YH, Yang YC, Lu FH, Sun ZJ, Wu JS, Chang CJ. Serum bilirubin is inversely associated with increased arterial stiffness in men with pre-hypertension but not normotension.Plos One. 2016;11:e146226–35.
   Google Scholar
• Erdogan D, Gullu H, Yildirim E, Tok D, Kirbas I, Ciftci O, Baycan ST, Muderrisoglu H. Low serum bilirubin levels are independently and inversely related to impaired flow-mediated vasodilation and increased carotid intima-media thickness in both men and women. Atherosclerosis. 2006;184:431–37. doi:10.1016/j.atherosclerosis.2005.05.011.
   PubMed Web of Science ®Google Scholar
• Mancuso C, Barone E, Guido P, Miceli F, Di Domenico F, Perluigi M, Santangelo R, Preziosi P. Inhibition of lipid peroxidation and protein oxidation by endogenous and exogenous antioxidants in rat brain microsomes in vitro. Neurosci Lett. 2012;518:101–05. doi:10.1016/j.neulet.2012.04.062.
   PubMed Web of Science ®Google Scholar
• Boon AC, Hawkins CL, Coombes JS, Wagner KH, Bulmer AC. Bilirubin scavenges chloramines and inhibits myeloperoxidase-induced protein/lipid oxidation in physiologically relevant hyperbilirubinemic serum. Free Radic Biol Med. 2015;86:259–68. doi:10.1016/j.freeradbiomed.2015.05.031.
   PubMed Web of Science ®Google Scholar
• Stocker R, Peterhans E. Antioxidant properties of conjugated bilirubin and biliverdin: biologically relevant scavenging of hypochlorous acid. Free Radic Res Commun. 1989;6:57–66.
   PubMed Web of Science ®Google Scholar
• Wu TW, Fung KP, Yang CC. Unconjugated bilirubin inhibits the oxidation of human low density lipoprotein better than Trolox. Life Sci. 1994;54:P477–81.
   PubMed Web of Science ®Google Scholar